Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
6.60
+0.97 (17.23%)
At close: May 15, 2025, 4:00 PM
6.66
+0.06 (0.91%)
After-hours: May 15, 2025, 7:51 PM EDT
Fulcrum Therapeutics Market Cap
Fulcrum Therapeutics has a market cap or net worth of $356.26 million as of May 15, 2025. Its market cap has decreased by -19.04% in one year.
Market Cap
356.26M
Enterprise Value
137.77M
1-Year Change
-19.04%
Ranking
Category
Stock Price
$6.60
Market Cap Chart
Since July 18, 2019, Fulcrum Therapeutics's market cap has increased from $301.64M to $356.26M, an increase of 18.11%. That is a compound annual growth rate of 2.90%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 645.01B |
Johnson & Johnson | 357.95B |
AbbVie | 313.89B |
Novo Nordisk | 288.64B |
UnitedHealth Group | 237.25B |
Abbott Laboratories | 229.73B |
Novartis AG | 208.47B |
AstraZeneca | 206.71B |